Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Capital Expenditures came in at $23000.0 in Q1 2026, down 14.81% year-on-year from $27000.0 in Q1 2025, and down 87.29% on a QoQ basis from $181000.0 in Q3 2025.
Tectonic Therapeutic (TECX) Capital Expenditures (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Capital Expenditures data on file, last reported at $23000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 14.81% year-over-year to $23000.0 in Q1 2026; TTM through Mar 2026 was $204000.0, a 1.45% decrease from a year earlier, with the FY2025 full-year figure at $208000.0, up 33.33% from the prior year.
- Capital Expenditures for Q1 2026 stood at $23000.0, down from $181000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for TECX reached as high as $267000.0 in Q4 2022 and fell as low as -$215000.0 in Q3 2023.
- Historically, Capital Expenditures has averaged $43933.3 across 5 years, with a median of $24000.0 in 2024.
- Across the five-year window, Capital Expenditures jumped 421.95% in 2023 and plunged 400.0% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $267000.0 in 2022, then tumbled by 100.75% to -$2000.0 in 2023, then soared by 250.0% to $3000.0 in 2024, then surged by 5933.33% to $181000.0 in 2025, then plunged by 87.29% to $23000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $23000.0 in Q1 2026, $181000.0 in Q3 2025, and $27000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 153,000.00 |
| Sep 30, 2024 | 153,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -215,000.00 |
| Sep 30, 2023 | -215,000.00 |
| Jun 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 214,000.00 |